ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET 2021-2028

Market By Device Type And Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific peripheral vascular devices market is expected to progress with a CAGR of 12.46% by revenue over the estimated period from 2021 to 2028.


The countries studied in this market are:

           China

           Japan

           India

           Australia & New Zealand

           South Korea

           ASEAN countries

           Rest of APAC countries

Diabetes is a very common condition in the Chinese population, and more than 10% of adults were reported to be suffering from it in 2017. China is estimated to have close to 183 million diabetics by 2045. The growing prevalence of this condition is expected to increase the rate of incidence of peripheral vascular disease as well. Further, the rapidly aging population is another factor leading to an enhanced occurrence of PVD. By the year 2026, China’s elderly population is estimated to grow and reach 200 million people. There were nearly 140 million people aged 65 years or above, and this population is expected to exceed over 200 million by 2026. People in this age group are highly vulnerable to diseases like PVD, and the growth in the geriatric populace will, in turn, raise the cases of the disease.

The above-stated factors like the growing prevalence of diabetes and the rising aging population are enhancing the demand for peripheral vascular devices. This growing demand will boost the peripheral vascular devices market growth in China in the coming years. Peripheral arterial disease (PAD) causes the narrowing of arteries apart from those associated with the brain and heart. As per a study published in Circulation Journal, there were close to 500,000 to 800,000 patients with atherosclerotic PAD in Japan in 2016. This high incidence rate of PAD has raised the demand for peripheral vascular devices. This is supporting the studied market growth in Japan.

Boston Scientific Corporation is a globally-renowned company developing, manufacturing, and marketing medical devices. The company’s products are used in a number of interventional medical specialties, such as interventional cardiology, interventional radiology, peripheral interventions, neurovascular intervention, neuromodulation, endoscopy, electrophysiology, vascular surgery, cardiac surgery, oncology, gynecology, and urology. Over the years, the company has built a strong brand portfolio and a reliable distribution network to cater to a major section of its potential market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET - SUMMARY 

2.    INDUSTRY OUTLOOK

2.1. KEY INSIGHTS      

2.1.1. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES          

2.1.2. PRODUCT RECALLS OWING TO SAFETY CONCERNS      

2.2. IMPACT OF COVID-19 ON THE PERIPHERAL VASCULAR DEVICES MARKET          

2.3. PORTERS FIVE FORCES ANALYSIS 

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS      

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS INDEX  

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. MERGER & ACQUISITIONS         

2.6.2. PRODUCT LAUNCH & DEVELOPMENTS        

2.6.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION  

2.6.4. BUSINESS EXPANSION   

2.7. MARKET DRIVERS         

2.7.1. MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE   

2.7.2. PROLIFERATING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE                

2.7.3. CONTINUOUS TECHNOLOGICAL ADVANCEMENTS

2.8. MARKET CHALLENGES

2.8.1. STRINGENT REGULATORY PROCESS

2.8.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES         

2.8.3. INTENSE COMPETITION  

2.9. MARKET OPPORTUNITIES       

2.9.1. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS          

2.9.2. MARKET POTENTIAL IN DEVELOPING COUNTRIES           

3. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET OUTLOOK – BY DEVICE TYPE     

3.1. PERIPHERAL VASCULAR STENTS    

3.1.1. SELF-EXPANDING PERIPHERAL VASCULAR STENTS      

3.1.2. BALLOON-EXPANDING PERIPHERAL VASCULAR STENTS          

3.1.3. DRUG-ELUTING PERIPHERAL VASCULAR STENTS

3.1.4. COVERED STENT  

3.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS 

3.2.1. STANDARD PTA BALLOON CATHETER          

3.2.2. HIGH-PRESSURE PTA BALLOON CATHETER           

3.2.3. LARGE PTA BALLOON CATHETER       

3.2.4. SMALL PTA BALLOON CATHETER       

3.2.5. SPECIALTY PTA BALLOON CATHETER          

3.2.6. DRUG COATED PTA BALLOON CATHETER   

3.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES        

3.4. ATHERECTOMY DEVICES        

3.5. EMBOLIC PROTECTION DEVICES     

3.6. INFERIOR VENA CAVA FILTERS         

3.7. OTHER DEVICE TYPES 

4.    ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET – COUNTRY OUTLOOK           

4.1. CHINA         

4.2. JAPAN        

4.3. INDIA           

4.4. SOUTH KOREA    

4.5. ASEAN COUNTRIES       

4.6. AUSTRALIA & NEW ZEALAND 

4.7. REST OF ASIA-PACIFIC

5.    COMPETITIVE LANDSCAPE

5.1. ABBOTT LABORATORIES         

5.2. ANGIOSCORE INC (SPECTRANETICS CORPORATION)  

5.3. BOSTON SCIENTIFIC CORPORATION          

5.4. BECTON DICKINSON AND COMPANY          

5.5. COOK GROUP      

5.6. CARDINAL HEALTH INC (CORDIS)     

5.7. EDWARDS LIFESCIENCES CORPORATION

5.8. ENDOLOGIX          

5.9. KONINKLIJKE PHILIPS NV        

5.10. MEDTRONIC PLC          

5.11. TELEFLEX MEDICAL    

5.12. TERUMO INTERVENTIONAL SYSTEMS INC          

6.    METHODOLOGY & SCOPE  

6.1. RESEARCH SCOPE & DELIVERABLES        

6.2. SOURCES OF DATA       

6.3. RESEARCH METHODOLOGY  

List of table

TABLE 1: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF MERGER & ACQUISITIONS

TABLE 5: LIST OF PRODUCT LAUNCH & DEVELOPMENTS

TABLE 6: LIST OF PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION

TABLE 7: LIST OF BUSINESS EXPANSION

TABLE 8: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2020 & 2028

FIGURE 3: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 4: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2020 & 2028

FIGURE 5: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SELF-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG-ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2020 & 2028

FIGURE 11: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 23: CHINA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: JAPAN PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: INDIA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

FIGURE 27: ASEAN COUNTRIES PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: AUSTRALIA & NEW ZEALAND PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: REST OF ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;